Hallie C Prescott, MD, MSc
Toews Family Legacy Professor of Pulmonary and Critical Care Medicine
Associate Professor of Internal Medicine
Medical School
Ann Arbor
MI
48109, United States
[email protected]

Available to mentor

Hallie C Prescott, MD, MSc
Associate Professor
  • About
  • Qualifications
  • Center Memberships
  • Research Overview
  • Recent Publications
  • Manage Your Profile
    About

    Dr. Hallie Prescott is an Associate Professor in Pulmonary & Critical Care Medicine at the University of Michigan and a staff physician the Ann Arbor Veterans Affairs Healthcare System. She completed pulmonary/critical care fellowship training in 2014 and currently attends in the Ann Arbor VA outpatient pulmonary clinic and medical intensive care unit, as well as in the Critical Care Medicine Unit at Michigan Medicine. She has a master’s degree in healthcare research, with broad methodological expertise in quantitative, qualitative, and survey research methods. The primary focus of her research program has been on sepsis care and outcomes. She serves as co-chair of the international Surviving Sepsis Campaign Guidelines and leads the Michigan Hospital Medicine Safety Consortium’s Sepsis Initiative. Dr. Prescott’s research contributions have been recognized by awards from American Thoracic Society, American Society of Clinical Innovation, Australia/New Zealand Intensive Care Society, and the Carol A. Kauffman MD Department of Internal Medicine Early Career Endowment Award (2019-2024) from the University of Michigan.

    Qualifications
    • MSc, Healthcare Research
      University of Michigan, 2014
    • MD
      The Ohio State University, 2007
    • BA
      Middlebury College, 2003
    Center Memberships
    • Center Member
      Institute for Healthcare Policy and Innovation
    Research Overview

    Dr. Hallie Prescott's research focuses on the measurement, management, and outcomes of sepsis.

    Recent Publications See All Publications
    • Journal Article
      Unsupervised clustering for sepsis identification in large-scale patient data: a model development and validation study
      Li N, Riazi K, Pan J, Thavorn K, Ziegler J, Rochwerg B, Quan H, Prescott HC, Dodek PM, Li B, Gervais A, Garland A. Intensive Care Medicine Experimental, 2025 Dec 1; 13 (1): DOI:10.1186/s40635-025-00744-w
    • Proceeding / Abstract / Poster
      Implementation of a Stroke Volume-Guided Fluid Protocol in the ICU: Experience at a Tertiary Care Center
      Munroe ES, Mulcahy R, Blank R, Dammeyer J, Didoszak S, Garcia T, Hyzy RC, King JE, McSparron JI, McFarlane C, Tran C, Park PK, Prescott HC. 2025 May 16;
    • Journal Article
      Reformulating patient stratification for targeting interventions by accounting for severity of downstream outcomes resulting from disease onset: a case study in sepsis.
      Kamran F, Tjandra D, Valley TS, Prescott HC, Shah NH, Liu VX, Horvitz E, Wiens J. J Am Med Inform Assoc, 2025 May 1; 32 (5): 905 - 913. DOI:10.1093/jamia/ocaf036
      PMID: PMC12012354
    • Journal Article
      Evidence-based personalised medicine in critical care: a framework for quantifying and applying individualised treatment effects in patients who are critically ill.
      Munroe ES, Spicer A, Castellvi-Font A, Zalucky A, Dianti J, Graham Linck E, Talisa V, Urner M, Angus DC, Baedorf-Kassis E, Blette B, Bos LD, Buell KG, Casey JD, Calfee CS, Del Sorbo L, Estenssoro E, Ferguson ND, Giblon R, Granholm A, Harhay MO, Heath A, Hodgson C, Houle T, Jiang C, Kramer L, Lawler PR, Leligdowicz A, Li F, Liu K, Maiga A, Maslove D, McArthur C, McAuley DF, Serpa Neto A, Oosthuysen C, Perner A, Prescott HC, Rochwerg B, Sahetya S, Samoilenko M, Schnitzer ME, Seitz KP, Shah F, Shankar-Hari M, Sinha P, Slutsky AS, Qian ET, Webb SA, Young PJ, Zampieri FG, Zarychanski R, Fan E, Semler MW, Churpek M, Goligher EC, Platform of Randomized Adaptive Clinical Trials in Critical Illness (PRACTICAL) investigators , Evidence-based Individualized Treatment Effects (EvITE) Group . Lancet Respir Med, 2025 Apr 15; DOI:10.1016/S2213-2600(25)00054-2
      PMID: 40250459
    • Journal Article
      Concordance of 30-Day Mortality and In-Hospital Mortality or Hospice Discharge After Sepsis.
      Prescott HC, Heath M, Jayaprakash N, Dantes RB, Rhee C, Posa PJ, Flanders SA. JAMA, 2025 Apr 9; DOI:10.1001/jama.2025.2526
      PMID: PMC11983289
    • Journal Article
      Accuracy of Intensivist Prognostications of within-ICU Deterioration and Development of Persistent Critical Illness: A Prospective Cohort Study.
      Viglianti EM, Thenappan A, Admon AJ, Byrd KM, Lee KT, Bohnert ASB, Iwashyna TJ, Prescott HC. Ann Am Thorac Soc, 2025 Apr 8; DOI:10.1513/AnnalsATS.202411-1174OC
      PMID: 40198113
    • Journal Article
      Goals of Care Assessment During Hospitalization for Sepsis.
      Cagino LM, Walzl E, McSparron JI, Heath M, Swaminathan L, White DB, Esteitie R, McLaughlin ES, Horowitz JK, Posa P, Taylor SP, Flanders SA, Prescott HC. Ann Am Thorac Soc, 2025 Apr 4; DOI:10.1513/AnnalsATS.202410-1041OC
      PMID: 40185082
    • Journal Article
      Albuterol Reuse to Reduce the Carbon Footprint of Pulmonary Function Testing
      Peirce A, Calkins K, Allen T, Lewis-Hawkins D, Prescott H, Rabin A. Annals of the American Thoracic Society, 2025 Jan 20;
    Featured News & Stories hospital beds in hallway
    Health Lab
    Using data to drive sepsis care
    Michigan Medicine expert, Hallie Prescott, M.D., discusses successful statewide efforts to improve sepsis treatment–and setting the bar for change at the national level
    Photo of Dr. Robert Dickson and Dr. Hallie Prescott
    Research News
    Weil members named inaugural holders of new professorships
    Dr. Robert Dickson and Dr. Hallie Prescott have been installed as the Galen B. Toews, M.D. Legacy Professor and the Toews Family Legacy Professor, respectively, in Pulmonary and Critical Care Medicine.
    lungs
    Health Lab
    The environmental toll of inhalers for asthma and COPD
    In a JAMA research letter, Medicare and Medicaid claims data were used to estimate the greenhouse gas emissions of inhalers using propellants versus those that are propellant-free in the United States.